GRTS
Gritstone Oncology Inc
Halal Rating :
Last Price
$2.46
Last updated:
Market Cap
-
7D Change
-30.72%
1 Year Change
-98.32%
Company Overview
Industries
Exchange
Next Earnings Date
Gritstone Bio is a clinical-stage biotechnology company developing cancer and infectious disease immunotherapies. The company focuses on developing personalized cancer treatments using neoantigen-based immunotherapies and vaccines. Their platform combines artificial intelligence with genomic sequencing to identify neoantigens that can be targeted by the immune system.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2024 | $921000.0 | $29.81m | - | $1.3m | 0.00% | 4.37% |
| March 31, 2024 | $1.74m | $42.84m | - | $1.3m | 0.00% | 3.03% |
| Dec. 31, 2023 | $10.38m | $42.07m | - | $1.22m | 0.00% | 2.89% |
Company Impact
Help us evaluate Gritstone Oncology Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.